Nature Reviews Critiques AI in Drug Discovery: Absence of Clinical Evidence
EricTopol · x · 2026-08-09
Eric Topol shares an in-depth review from Nature Reviews Drug Discovery assessing a decade of AI in drug discovery. The authors conclude that the field is still at a stage with an 'absence of evidence' when it comes to translating AI into clinically relevant impact.
Related event: Nature Review: AI Drug Discovery Lacks Clinical Impact(2 posts)→
More from Research
- MLCommons launches MLPerf Endpoints, a benchmark that measures inference endpoints the way buyers actually purchase them — TheKanter · 2026-10-16
- DIY LEGO bench tests AI brick-building, GPT-6 Astra beats Opus — TheLegoless · 2026-10-16
- tszzl's theory: Tornado → Apache license → apaches → Southwest → Colorado — tszzl · 2026-10-16
- DIRECT: retrieval-based next-question suggestions for conversational agents — burkov · 2026-10-16
- A Qwen3 neuron tracks both Colorado and Tornado HTTP code; tszzl offers a theory — tszzl · 2026-10-16
- AI-Driven Timing-Aware Power Optimization Uses Learned Ranking With Baseline-Preserving Repair — Amit Sharma · 2026-10-16